Navigation Links
Imagenetix, Inc. Reports Year End Results
Date:6/17/2009

/p>

Certain matters in this news release are forward-looking statements which are subject to risks and uncertainties that could cause actual results to vary materially from those projected. Such risks and uncertainties include, but are not limited to, adverse fluctuations in future operating results due to a number of economic, competitive, and other factors, including, among other things, the size and timing of customer contracts, new or increased competition, changes in market demand, and seasonality of purchases of the company's products and services. Additional information with respect to these and other factors, which could materially affect the company and its operations, are included in the company's SEC filings, including its Form 10-K for the year ended March 31, 2008.

                               Imagenetix, Inc.
              Condensed Consolidated Statements of Operations
                   (In thousands, except per share data)

                                                       Year Ended
                                                        March 31,
                                                       ----------
                                                    2009       2008
                                                    ----       ----

    Net sales                                     $7,461      $5,570
     Cost of sales                                 4,003       3,344
                                                   -----       -----
    Gross profit                                   3,458       2,226
                                                   -----       -----
    Gross profit percent                            46.3%       40.0%

    Operating expenses:
      General and administrative                   2,241       2,456
      Payroll expense                              1,077       1,038
      Consulting expense                           1,059         962
    
'/>"/>
SOURCE Imagenetix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Imagenetix, Inc. Reports Third Quarter and Nine Month Results
2. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
3. Haemacure Reports Third Quarter 2007 Results
4. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
5. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
6. MDS Reports Third Quarter 2007 Results
7. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
8. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
9. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
10. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
11. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...swire/-SentinelleMedicalInc.,aleadingmanufacturero...nchesasuiteofnewleadingedgeclinicalapplicationsoni...r,sRadiologicalSocietyofNorthAmerica(RSNA)annualme...Theapplicationsleveragetheuniquehighqualityimagesg...dsupportmultipleimagingmodalitiesformulti-parametr...
(Date:11/25/2009)....25/PRNewswire-USNewswire/--AnarticlebyJanetWoodco...ndResearch,titled"ADifficultBalance-PainManagement...eofTheNewEnglandJournalofMedicine. ,, (Logo: ht... ) ,, Inthearticle,WoodcockdiscussesFDAeffortst...sewhoneeditandmanagingtherisksposedbyvariousanalge...
(Date:11/25/2009)...PRNewswire/--TheBayAreaAirQualityManagementDistric... Air Alert forThursday,November26,2009which...dfuel,bothindoorsandoutdoors. ,, "Cold,stillwea...aidJackBroadbent,executiveofficeroftheAirDistrict....eirneighborsandfellowcommunitymembersthisThanksgiv...
(Date:11/25/2009)...ticular cancer who were treated with cisplatin-bas...uding neurological side effects and Raynaud-like p...therapy, according to a new study published online...r Institute . , Marianne Brydy, M.D., of the Dep..., in Bergen, Norway, and colleagues conducted a cr...
(Date:11/25/2009)...hat grew out of a collaboration between UCLA engin...o the nearly 10 million Americans who suffer from ... hardening of the arteries, peripheral arterial di...which narrowed arteries reduce blood flow to the l...ascular disease, heart attack and stroke, and its ...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4
...Dutch Vaccine Guarantor Selects Sparta Systems, So...Across the Organization , , HOLMDEL, N.J., March ...erprise quality and compliance management software... the Dutch population, has selected the TrackWise ...
... An unlikely brew of seaweed and glow-in-the-dark ...e of transplanted stem cells to treat patients wit...ing to a team of veterinarians, basic scientists a...ully delivered therapeutic stem cells via intramus...
... Arnhem, 10 March 2009 -- The standard Prostate Sp...ot tell the difference between aggressive and slow...will be held from 17 to 21 March 2009 in Stockholm... aggressive and non-aggressive prostate cancers: s...
...Ankle Brachial Index (ABI) Identifies Peripheral A...sk Who Were Missed by Framingham Risk Score in 6,2...ch 10 The use of common and readily available scr...o prevent devastating heart attacks in thousands o...
...Interventional Radiologists Help Peripheral Arteri...mia Avoid Amputation , , SAN DIEGO, March 10 At...al arterial disease (PAD) patients with below-the-...nts and the continued progression of atherosclerot...
...Certification Underscores Lionbridge,s Market-Lead...es Organizations Worldwide , , WALTHAM, Mass., Ma...ed that it recently received ISO 13485:2003 certif...m and enhances the Company,s translation managemen...
Other Medicine News:Health News:Netherlands Vaccine Institute Chooses TrackWise(R) Solution for Enterprise-wide Compliance with Good Manufacturing Practices 2Health News:Netherlands Vaccine Institute Chooses TrackWise(R) Solution for Enterprise-wide Compliance with Good Manufacturing Practices 3Health News:Netherlands Vaccine Institute Chooses TrackWise(R) Solution for Enterprise-wide Compliance with Good Manufacturing Practices 4Health News:Seaweed and fireflies brew may guide stem cell treatment for peripheral artery disease 2Health News:Dr. Arun Sreekumar lectures on new candidate biomarker at Annual EAU Congress 2Health News:Simple Test Helps Predict Heart Attack Risk 2Health News:Simple Test Helps Predict Heart Attack Risk 3Health News:Simple Test Helps Predict Heart Attack Risk 4Health News:Promising Three-year Data: Saving Limbs With Drug-Eluting Stents 2Health News:Promising Three-year Data: Saving Limbs With Drug-Eluting Stents 3Health News:Promising Three-year Data: Saving Limbs With Drug-Eluting Stents 4Health News:Lionbridge Receives ISO 13485:2003 Certification for Quality Management 2
(Date:11/25/2009)..., PHILADELPHIA,Nov.25/PRNewswire-FirstCall/--ERT(N...ey,theCompany,sPresidentandCEO,andKeithSchneck,the...topresentatthe21stAnnualPiperJaffrayHealthCareConf...York. ,, Interestedpartiesmayaccessthepresentat.../www.ert.com .Thewebcastmayalsobeaccessedat http:/...
(Date:11/25/2009)..., EXTON,Pa.,Nov.25/PRNewswire/--BioTrendsResearchG...Stelara report,thefirstinamulti-phasesyndicatedma...o-Biotech,sStelara,fromproductlaunchthroughthefirs...esquantitativeinformationfrom75uniqueDermatologist...tsassesstrialanduseofStelara,obstaclestouse,typica...
(Date:11/25/2009)..., WESTPALMBEACH,Fla.,Nov.25/PRNewswire-FirstCall/-...peciallythe27millionlivingwithuntreated hearinglos...CindyBeyer. ,, Dr.Beyer,seniorvicepresidentofHe...and hearingaids companies,saidstudieshavelinkedhea...hichcaneasilybeintensifiedatholidaygatheringswithf...
Breaking Medicine Technology:ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2iPierian Appoints Dr Matthew J Plunkett as Chief Financial Officer 13765 1iPierian Appoints Dr Matthew J Plunkett as Chief Financial Officer 13765 2Chemotherapy Linked to Sleep Wake Cycle Disruptions 55838 1Chemotherapy Linked to Sleep Wake Cycle Disruptions 55838 2National Changing Diabetes Program Supports Improvements in Health Cost Estimates 55833 1National Changing Diabetes Program Supports Improvements in Health Cost Estimates 55833 2National Changing Diabetes Program Supports Improvements in Health Cost Estimates 55833 3National Changing Diabetes Program Supports Improvements in Health Cost Estimates 55833 4National Changing Diabetes Program Supports Improvements in Health Cost Estimates 55833 5
..., 2007 /PRNewswire-FirstCall/ - Helix today,announ...udy of its,Topical Interferon Alpha-2b in women wi...ervical lesions. , The study showed a clinically e... the treated patients. In addition, the product,de...gnificant local,intolerance or drug-related seriou...
...ith Diabetes, Hospital,and Professional Charges Lo..., April 02, 2007 /PRNewswire-FirstCall/ -- The,Pit...today the,release of a new report on the prevalenc...2 diabetes. The inaugural Pittsburgh Type,2 Diabet...,demographics, hospital and professional charges, ...
Other Medicine Technology:Helix BioPharma Corp. Announces Positive Phase II Clinical Results,with its Topical Interferon Alpha-2b 2Helix BioPharma Corp. Announces Positive Phase II Clinical Results,with its Topical Interferon Alpha-2b 3Helix BioPharma Corp. Announces Positive Phase II Clinical Results,with its Topical Interferon Alpha-2b 4Helix BioPharma Corp. Announces Positive Phase II Clinical Results,with its Topical Interferon Alpha-2b 5Helix BioPharma Corp. Announces Positive Phase II Clinical Results,with its Topical Interferon Alpha-2b 6State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 2State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 3State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 4
...areCollect™ improves the specimen collection ... patient information on the handheld at the bedsid...pecific patient. Collection status information can...educe redraws, enhancing patient comfort, and maki...
...rizon Admin-Rx is a bar-code medication administra...the medication administration process with bar-cod...canner in a handheld or laptop device to verify th... at the right time in the right dosage via the rig...
wCareMed™
...diMAR™ is the newest Mediware product, which ...record. MediMAR produces a dynamic and complete re...including clinician orders, medication list, aller...ion or alerts that increase patient safety. MediMA...
Medicine Products: